Read my new editorial in the @indianjnephrol on how we fall on the hurdle of implementing high-value, guideline-directed therapies to our patients with chronic diseases t.co/Tqy7fp9N1R
Read my new editorial in the @indianjnephrol on how we fall on the hurdle of implementing high-value, guideline-directed therapies to our patients with chronic diseases t.co/Tqy7fp9N1R
ISN-@kdigo.org joint session: "Implementing Updated KDIGO AKI/AKD Guidelines Worldwide" 🗓️ March 29 🕤 9:25 a.m. 📍 501-502 @vjha.bsky.social #ISNWCN
𝗜𝗦𝗡 𝗔𝘄𝗮𝗿𝗱𝘀: 🇮🇳 @vjha.bsky.social , winner of the 𝗝𝗲𝗮𝗻 𝗛𝗮𝗺𝗯𝘂𝗿𝗴𝗲𝗿 𝗔𝘄𝗮𝗿𝗱 🇺🇸 John Kellum, winner of the 𝗕𝘆𝘄𝗮𝘁𝗲𝗿𝘀 𝗔𝘄𝗮𝗿𝗱 🇳🇱 Ron Gansevoort, winner of the 𝗟𝗶𝗹𝗹𝗶𝗮𝗻 𝗝𝗲𝗮𝗻 𝗞𝗮𝗽𝗹𝗮𝗻 𝗣𝗿𝗶𝘇𝗲 𝗳𝗼𝗿 𝗣𝗞𝗗 #ThisIsISN #ISNAwards #ISNWCN
🎙️ Check out the latest Global Kidney Care Podcast! Winston Fung leads a discussion on how climate change is shaping kidney health 🌎 with Prof. @vjha.bsky.social, Maryvonne Hourmant, @sfndt.bsky.social Past president, and Letizia De Chiara. globalkidneycarepodcast.transistor.fm/episodes/sea...
Our Nutrition team took India’s voices to the global stage at 23rd IUNS International Congress of Nutrition in Paris. With 7 presentations, they showcased Indigenous food systems, dietary diversity, child feeding practices, food procurement, Indian adaptation of the Mediterranean diet & more. [1/2]
🏅 Prof. Vivekanand Jha @vjha.bsky.social (India), winner of the Jean Hamburger Award lite.spr.ly/6000KvmY
First randomization in India for EASi-KIDNEY!🎉🥳 Big thanks to and the PGIMER team for leading the start, and to all our partner sites for their commitment and support. Also to the fantastic colleagues at @georgeinstitute.bsky.social and Oxford NDPH www.easikidney.org
Welcome
EASi-KIDNEY is an international, multi-centre, randomised double-blind placebo-controlled trial to assess whether in addition to standard care, the drug vicadrostat reduces the risk of kidney disease ...
easikidney.org
New study: NOACs like apixaban safe & effective for short-term prevention of blood clots in primary membranous nephropathy patients with low albumin—no VTEs, low bleeding risk. Promising alternative to warfarin! #Nephrology #VTE #PatientCare t.co/mSt3nhKMvm @isn-india.bsky.social
https://indianjnephrol.org/apixaban-in-primary-membranous-nephropathy-report-from-the-itangible-registry/
t.co
Listen to Dr Vasistha Tatapudi of from focusing on the use of pig kidneys in humans - the rationale, immunological challenges, and genetic modifications involved in overcoming hyperacute rejection. t.co/Htzs11a711
https://youtu.be/pbumiUjck1I?si=CShZCu48Gw3Ws84Z
t.co
Nice case and good discussion on how to interpret clinical clues
Case Presentations in Nephrology - An Indian Society of Nephrology Initiative YouTube Recording 👉 m.youtube.com/watch?v=0yuO... Topic: Case of Anasarca Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social Presented by - Dr Jugal Mehta (Mumbai)
Case Presentations in Nephrology - An Indian Society of Nephrology Initiative YouTube Recording 👉 m.youtube.com/watch?v=0yuO... Topic: Case of Anasarca Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social Presented by - Dr Jugal Mehta (Mumbai)
Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease frontiersin.org/journals/imm... @vjha.bsky.social
Frontiers | Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease
frontiersin.org
Congratulations to Dr Jha and the team! Collaboration and data sharing is the way forward! 🇮🇳🏖️
Presenting #iTANGIBLE - a nationwide Indian collaborative effort to study common primary glomerular diseases in India. ➡️ The first such cohort in the developing (majority) world ➡️ Will help understand disease phenotypes in the Indian context Funded by #ICMR www.kireports.org/article/S246...
Presenting #iTANGIBLE - a nationwide Indian collaborative effort to study common primary glomerular diseases in India. ➡️ The first such cohort in the developing (majority) world ➡️ Will help understand disease phenotypes in the Indian context Funded by #ICMR www.kireports.org/article/S246...
Decoding Glomerular Disease: Baseline Profiles and Insights From the I-TANGIBLE Registry
Glomerular diseases are a leading cause of kidney disease worldwide, especially in low-and middle-income countries. At the global level, collaborative initiatives have been started to provide informat...
kireports.org
Happy 20th anniversary #WorldKidneyDay 🎉 Two decades of successful awareness campaigns! On this year, WKD invites you to ask yourself #AreYourKidneysOK? Knowing the answer to this question can detect signs of early kidney disease and prevent it from worsening.
Remembering Bill Couser who we lost recently on this #WKD for his huge contributions to conceiving this initiative that has made such a difference to kidney health awareness around the world @theisn.org www.kidney-international.org/article/S008...
🌎Are your kidneys OK? ¿Tus riñones están bien? Vos reins vont bien? هل كليتيك بخير؟ ; आपकी किडनी ठीक है? Os seus rins estão bem? @theisn.org @drpriyajohn.bsky.social @nephromythri.bsky.social @sabinekaram.bsky.social #WorldKidneyDay #KidneyHealthForAll #NephSky #BlueSky
Congratulations Vivek on the broad swathe of holistic science presented at WCN in New Delhi. It was an outstanding meeting! @vjha.bsky.social @charumalik.bsky.social @asnkidney.bsky.social @uncdeptmedicine.bsky.social
@vjha.bsky.social welcoming the audience to India and #ISNWCN
"Decoding Glomerulonephritis: Baseline Profiles and Insights from the I-TANGIBLE Registry" by Kavita Yadav, @vjha.bsky.social et al. 🔗 Download the visual abstract by @sayalibthakare.bsky.social www.theisn.org/wcn/w... #ISNWCN
First steps in efforts to characterise the burden of CKDu across different regions. Fantastic work led by Charlotte in collaboration with so many brilliant investigators from around the world. If we understand where it is, maybe we can understand what it is. with @vjha.bsky.social and others
International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from a population-based cross-sectional disadvantaged populations #eGFR epidemiology (DEGREE) study doi.org/10.1016/j.kint.2024.11.028 #CKDu #CKDnt #chronickidneydisease #NephSky #MedSky
🌍 Dialysis in LMICs: A Lesson from Thailand Thailand’s PD-first policy (2008-2022) transformed dialysis care, saving lives and reducing poverty. But a 2022 shift to patient choice revealed unintended consequences. Lessons for universal health coverage worldwide. #UHC #GlobalHealth
Good noon all, IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live. Kindly follow the link: indianjnephrol.org/current-issue/ @arvindcanchi.bsky.social @priti899.bsky.social
2024 – A Year in Review - Indian Journal of Nephrology
[article]
indianjnephrol.org
Good noon all, IJN: Year: 2025, Volume: 35, Issue: 1, January-February Issue of Indian Journal of Nephrology is live. Kindly follow the link: indianjnephrol.org/current-issue/ @arvindcanchi.bsky.social @priti899.bsky.social
2024 – A Year in Review - Indian Journal of Nephrology
[article]
indianjnephrol.org
The Limits of Generalizability: Pitfalls of Applying Western #GFR Estimation Models to Global Populations doi.org/10.1016/j.ek... Original Article: doi.org/10.1016/j.ek... #KIRCommentary
‘A letter by Richard Lambert, former editor of the Financial Times, gives a fascinating insight into how Manmohan Singh was not just about economic reforms, but reforms with a heart.’ From - The India Cable by @thewire.in
📖 Don't miss our KI #ISNFridaySelection: Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipients www.kidney-internati... #NephSky
Excited to see the Global Kidney Patient Trials Network (GKPTN) featured in @jama.com! Endorsed by ISN, this initiative is transforming CKD research and improving access to innovative treatments worldwide. Learn more: jamanetwork.com/jour... #Nephsky @vjha.bsky.social